-
1
-
-
33846975880
-
The structure of hyalobiuronic and of hyaluronic acid from umbilical cord
-
Weissmann B, Meyer K. The structure of hyalobiuronic and of hyaluronic acid from umbilical cord. J Am Chem Soc 1954;76:1753-7.
-
(1954)
J Am Chem Soc
, vol.76
, pp. 1753-1757
-
-
Weissmann, B.1
Meyer, K.2
-
3
-
-
0026028982
-
Secondary and tertiary structures of hyaluronan in aqueous solution, investigated by rotary shadowing-electron microscopy and computer simulation: Hyaluronan is a very efficient network-forming polymer
-
Scott JE, Cummings C, Brass A, Chen Y. Secondary and tertiary structures of hyaluronan in aqueous solution, investigated by rotary shadowing-electron microscopy and computer simulation: hyaluronan is a very efficient network-forming polymer. Biochem J 1991;274:699-705.
-
(1991)
Biochem J
, vol.274
, pp. 699-705
-
-
Scott, J.E.1
Cummings, C.2
Brass, A.3
Chen, Y.4
-
4
-
-
0027504082
-
Hyaluronan-binding proteins in development, tissue homeostasis, and disease
-
Knudson CB, Knudson W. Hyaluronan-binding proteins in development, tissue homeostasis, and disease. FASEB J 1993;7:1233-41.
-
(1993)
FASEB J
, vol.7
, pp. 1233-1241
-
-
Knudson, C.B.1
Knudson, W.2
-
5
-
-
33746040501
-
Hyaluronan fragments: An information-rich system
-
Stern R, Asari AA, Sugahara KN. Hyaluronan fragments: an information-rich system. Eur J Cell Bio 2006;85:699-715.
-
(2006)
Eur J Cell Bio
, vol.85
, pp. 699-715
-
-
Stern, R.1
Asari, A.A.2
Sugahara, K.N.3
-
6
-
-
0031947020
-
Joint physiology: Relevant to the rheumatologist?
-
Edwards JC, Morris V. Joint physiology: relevant to the rheumatologist? Br J Rheumatol 1998;37:121-5.
-
(1998)
Br J Rheumatol
, vol.37
, pp. 121-125
-
-
Edwards, J.C.1
Morris, V.2
-
7
-
-
33646520638
-
The clinical impact of physical-chemical characteristics of different hyaluronic acids as a treatment for osteoarthritis
-
Sanchez-Lazaro J, Diaz-Gallego L. The clinical impact of physical-chemical characteristics of different hyaluronic acids as a treatment for osteoarthritis. Int J Biol Macromol 2006;38:300-1.
-
(2006)
Int J Biol Macromol
, vol.38
, pp. 300-301
-
-
Sanchez-Lazaro, J.1
Diaz-Gallego, L.2
-
8
-
-
0028360747
-
An agarose gel electrophoretic method for analysis of hyaluronan molecular weight distribution
-
Lee HG, Cowman MK. An agarose gel electrophoretic method for analysis of hyaluronan molecular weight distribution. Anal Biochem 1994;219:278-87.
-
(1994)
Anal Biochem
, vol.219
, pp. 278-287
-
-
Lee, H.G.1
Cowman, M.K.2
-
9
-
-
0022343146
-
Concentration and molecular weight of sodium hyaluronate in synovial fluid from patients with rheumatoid arthritis and other arthropathies
-
Dahl LB, Dahl IM, Engstrom-Laurent A, Granath K. Concentration and molecular weight of sodium hyaluronate in synovial fluid from patients with rheumatoid arthritis and other arthropathies. Ann Rheum Dis 1985;44:817-22.
-
(1985)
Ann Rheum Dis
, vol.44
, pp. 817-822
-
-
Dahl, L.B.1
Dahl, I.M.2
Engstrom-Laurent, A.3
Granath, K.4
-
11
-
-
0021927509
-
Hyaluronic acid production in vitro by synovial lining cells from normal and rheumatoid joints
-
Dahl IM, Husby G. Hyaluronic acid production in vitro by synovial lining cells from normal and rheumatoid joints. Ann Rheum Dis 1985;44:647-57.
-
(1985)
Ann Rheum Dis
, vol.44
, pp. 647-657
-
-
Dahl, I.M.1
Husby, G.2
-
12
-
-
0027588232
-
High molecular weight sodium hyaluronate (hyalectin) in osteoarthritis of the knee: A 1 year placebo-controlled trial
-
Dougados M, Nguyen M, Listrat V, Amor B. High molecular weight sodium hyaluronate (hyalectin) in osteoarthritis of the knee: a 1 year placebo-controlled trial. Osteoarthritis Cartilage 1993;1:97-103.
-
(1993)
Osteoarthritis Cartilage
, vol.1
, pp. 97-103
-
-
Dougados, M.1
Nguyen, M.2
Listrat, V.3
Amor, B.4
-
13
-
-
0029588227
-
The role of viscosupplementation with hylan G-F 20 (Synvisc) in the treatment of osteoarthritis of the knee: A Canadian multicenter trial comparing hylan G-F 20 alone, hylan G-F 20 with non-steroidal anti-inflammatory drugs (NSAIDs) and NSAIDs alone
-
Adams ME, Atkinson MH, Lussier AJ, Schulz JI, Siminovitch KA, Wade JP, et al. The role of viscosupplementation with hylan G-F 20 (Synvisc) in the treatment of osteoarthritis of the knee: a Canadian multicenter trial comparing hylan G-F 20 alone, hylan G-F 20 with non-steroidal anti-inflammatory drugs (NSAIDs) and NSAIDs alone. Osteoarthritis Cartilage 1995;3:213-25.
-
(1995)
Osteoarthritis Cartilage
, vol.3
, pp. 213-225
-
-
Adams, M.E.1
Atkinson, M.H.2
Lussier, A.J.3
Schulz, J.I.4
Siminovitch, K.A.5
Wade, J.P.6
-
14
-
-
0033849616
-
Intra-articular hyaluronan therapy
-
Marshall KW. Intra-articular hyaluronan therapy. Curr Opin Rheumatol 2000;12:468-74.
-
(2000)
Curr Opin Rheumatol
, vol.12
, pp. 468-474
-
-
Marshall, K.W.1
-
15
-
-
0033609860
-
Three isoforms of mammalian hyaluronan synthases have distinct enzymatic properties
-
Itano N, Sawai T, Yoshida M, Lenas P, Yamada Y, Imagawa M, et al. Three isoforms of mammalian hyaluronan synthases have distinct enzymatic properties. J Biol Chem 1999;274:25085-92.
-
(1999)
J Biol Chem
, vol.274
, pp. 25085-25092
-
-
Itano, N.1
Sawai, T.2
Yoshida, M.3
Lenas, P.4
Yamada, Y.5
Imagawa, M.6
-
16
-
-
0035865681
-
Differential regulation and expression of hyaluronan synthases in human articular chondrocytes, synovial cells and osteosarcoma cells
-
Recklies AD, White C, Melching L, Roughley PJ. Differential regulation and expression of hyaluronan synthases in human articular chondrocytes, synovial cells and osteosarcoma cells. Biochem J 2001;354:17-24.
-
(2001)
Biochem J
, vol.354
, pp. 17-24
-
-
Recklies, A.D.1
White, C.2
Melching, L.3
Roughley, P.J.4
-
17
-
-
1242342214
-
Glucocorticoids inhibit induced and non-induced mRNA accumulation of genes encoding hyaluronan synthases (HAS): Hydrocortisone inhibits HAS1 activation by blocking the p38 mitogen-activated protein kinase signalling pathway
-
Stuhlmeier KM, Pollaschek C. Glucocorticoids inhibit induced and non-induced mRNA accumulation of genes encoding hyaluronan synthases (HAS): hydrocortisone inhibits HAS1 activation by blocking the p38 mitogen-activated protein kinase signalling pathway. Rheumatology (Oxford) 2004;43:164-9.
-
(2004)
Rheumatology (Oxford)
, vol.43
, pp. 164-169
-
-
Stuhlmeier, K.M.1
Pollaschek, C.2
-
18
-
-
0029758948
-
Comparison of the antiinflammatory efficacy of chondroitin sulfate and diclofenac sodium in patients with knee osteoarthritis
-
Morreale P, Manopulo R, Galati M, Boccanera L, Saponati G, Bocchi L. Comparison of the antiinflammatory efficacy of chondroitin sulfate and diclofenac sodium in patients with knee osteoarthritis. J Rheumatol 1996;23:1385-91.
-
(1996)
J Rheumatol
, vol.23
, pp. 1385-1391
-
-
Morreale, P.1
Manopulo, R.2
Galati, M.3
Boccanera, L.4
Saponati, G.5
Bocchi, L.6
-
19
-
-
0031781240
-
Anti-inflammatory activity of chondroitin sulfate
-
Ronca F, Palmieri L, Panicucci P, Ronca G. Anti-inflammatory activity of chondroitin sulfate. Osteoarthritis Cartilage 1998;6 Suppl A:14-21.
-
(1998)
Osteoarthritis Cartilage
, vol.6
, Issue.SUPPL. A
, pp. 14-21
-
-
Ronca, F.1
Palmieri, L.2
Panicucci, P.3
Ronca, G.4
-
20
-
-
0031750348
-
Efficacy and tolerability of oral chondroitin sulfate as a symptomatic slow-acting drug for osteoarthritis (SYSADOA) in the treatment of knee osteoarthritis
-
Bucsi L, Poor G. Efficacy and tolerability of oral chondroitin sulfate as a symptomatic slow-acting drug for osteoarthritis (SYSADOA) in the treatment of knee osteoarthritis. Osteoarthritis Cartilage 1998;6 Suppl A:31-6.
-
(1998)
Osteoarthritis Cartilage
, vol.6
, Issue.SUPPL. A
, pp. 31-36
-
-
Bucsi, L.1
Poor, G.2
-
21
-
-
0031801950
-
Efficacy and tolerability of chondroitin sulfate 1200 mg/day vs chondroitin sulfate 3 × 400 mg/day vs placebo
-
Bourgeois P, Chales G, Dehais J, Delcambre B, Kuntz JL, Rozenberg S. Efficacy and tolerability of chondroitin sulfate 1200 mg/day vs chondroitin sulfate 3 × 400 mg/day vs placebo. Osteoarthritis Cartilage 1998;6 Suppl A:25-30.
-
(1998)
Osteoarthritis Cartilage
, vol.6
, Issue.SUPPL. A
, pp. 25-30
-
-
Bourgeois, P.1
Chales, G.2
Dehais, J.3
Delcambre, B.4
Kuntz, J.L.5
Rozenberg, S.6
-
22
-
-
0006605063
-
Efficacy and tolerability of 800 mg oral chondroitin 4&6 sulfate in the treatment of knee osteoarthritis: A randomised, double-blind, multicentre study versus placebo
-
Malaise M, Marcolongo R, Uebelhart D, Vignon E. Efficacy and tolerability of 800 mg oral chondroitin 4&6 sulfate in the treatment of knee osteoarthritis: a randomised, double-blind, multicentre study versus placebo. Litera Rheumatologica 1999;24:31-42.
-
(1999)
Litera Rheumatologica
, vol.24
, pp. 31-42
-
-
Malaise, M.1
Marcolongo, R.2
Uebelhart, D.3
Vignon, E.4
-
23
-
-
3142521811
-
The pathobiology of osteoarthritis and the rationale for using the chondroitin sulfate for its treatment
-
Volpi N. The pathobiology of osteoarthritis and the rationale for using the chondroitin sulfate for its treatment. Curr Drug Targets Immune Endocr Metabol Disord 2004;4:119-27.
-
(2004)
Curr Drug Targets Immune Endocr Metabol Disord
, vol.4
, pp. 119-127
-
-
Volpi, N.1
-
24
-
-
0343698374
-
Glucosamine and chondroitin for treatment of osteoarthritis: A systematic quality assessment and meta-analysis
-
McAlindon TE, LaValley MP, Gulin JP, Felson DT. Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis. JAMA 2000;283:1469-75.
-
(2000)
JAMA
, vol.283
, pp. 1469-1475
-
-
McAlindon, T.E.1
LaValley, M.P.2
Gulin, J.P.3
Felson, D.T.4
-
25
-
-
33344461287
-
Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis
-
Clegg DO, Reda DJ, Harris CL, Klein MA, O'Dell JR, Hooper MM, et al. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. N Engl J Med 2006;354:795-808.
-
(2006)
N Engl J Med
, vol.354
, pp. 795-808
-
-
Clegg, D.O.1
Reda, D.J.2
Harris, C.L.3
Klein, M.A.4
O'Dell, J.R.5
Hooper, M.M.6
-
26
-
-
0032076537
-
Effects of chondroitin sulfate and interleukin-1β on human articular chondrocytes cultivated in clusters
-
Bassleer CT, Combal JP, Bougaret S, Malaise M. Effects of chondroitin sulfate and interleukin-1β on human articular chondrocytes cultivated in clusters. Osteoarthritis Cartilage 1998;6:196-204.
-
(1998)
Osteoarthritis Cartilage
, vol.6
, pp. 196-204
-
-
Bassleer, C.T.1
Combal, J.P.2
Bougaret, S.3
Malaise, M.4
-
27
-
-
18244379294
-
Glucosamine and chondroitin sulfate regulate gene expression and synthesis of nitric oxide and prostaglandin E2 in articular cartilage explants
-
Chan PS, Caron JP, Rosa GJ, Orth MW. Glucosamine and chondroitin sulfate regulate gene expression and synthesis of nitric oxide and prostaglandin E2 in articular cartilage explants. Osteoarthritis Cartilage 2005;13:387-94.
-
(2005)
Osteoarthritis Cartilage
, vol.13
, pp. 387-394
-
-
Chan, P.S.1
Caron, J.P.2
Rosa, G.J.3
Orth, M.W.4
-
28
-
-
30744472413
-
Effect of glucosamine and chondroitin sulfate on regulation of gene expression of proteolytic enzymes and their inhibitors in interleukin-1-challenged bovine articular cartilage explants
-
Chan PS, Caron JP, Orth MW. Effect of glucosamine and chondroitin sulfate on regulation of gene expression of proteolytic enzymes and their inhibitors in interleukin-1-challenged bovine articular cartilage explants. Am J Vet Res 2005;66:1870-6.
-
(2005)
Am J Vet Res
, vol.66
, pp. 1870-1876
-
-
Chan, P.S.1
Caron, J.P.2
Orth, M.W.3
-
29
-
-
38349193381
-
Chondroitin sulfate modulation of matrix and inflammatory gene expression in IL-1β-stimulated chondrocytes - study in hypoxic alginate bead cultures
-
Legendre F, Bauge C, Roche R, Saurel AS, Pujol JP. Chondroitin sulfate modulation of matrix and inflammatory gene expression in IL-1β-stimulated chondrocytes - study in hypoxic alginate bead cultures. Osteoarthritis Cartilage 2008;16:105-14.
-
(2008)
Osteoarthritis Cartilage
, vol.16
, pp. 105-114
-
-
Legendre, F.1
Bauge, C.2
Roche, R.3
Saurel, A.S.4
Pujol, J.P.5
-
30
-
-
0031748965
-
Enhanced synovial production of hyaluronic acid may explain rapid clinical response to high-dose glucosamine in osteoarthritis
-
McCarty MF. Enhanced synovial production of hyaluronic acid may explain rapid clinical response to high-dose glucosamine in osteoarthritis. Med Hypotheses 1998;50:507-10.
-
(1998)
Med Hypotheses
, vol.50
, pp. 507-510
-
-
McCarty, M.F.1
-
31
-
-
0029080995
-
Enzyme-linked hyaluronectin: A unique reagent for hyaluronan assay and tissue location and for hyaluronidase activity detection
-
Delpech B, Bertrand P, Maingonnat C, Girard N, Chauzy C. Enzyme-linked hyaluronectin: a unique reagent for hyaluronan assay and tissue location and for hyaluronidase activity detection. Anal Biochem 1995;229:35-41.
-
(1995)
Anal Biochem
, vol.229
, pp. 35-41
-
-
Delpech, B.1
Bertrand, P.2
Maingonnat, C.3
Girard, N.4
Chauzy, C.5
-
32
-
-
0023277545
-
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
-
Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
-
(1987)
Anal Biochem
, vol.162
, pp. 156-159
-
-
Chomczynski, P.1
Sacchi, N.2
-
34
-
-
0037769541
-
TSG-6: A multifunctional protein associated with inflammation
-
Milner CM, Day AJ. TSG-6: a multifunctional protein associated with inflammation. J Cell Sci 2003;116:1863-73.
-
(2003)
J Cell Sci
, vol.116
, pp. 1863-1873
-
-
Milner, C.M.1
Day, A.J.2
-
35
-
-
0242412978
-
Elevated hyaluronan production induces mesenchymal and transformed properties in epithelial cells
-
Zoltan-Jones A, Huang L, Ghatak S, Toole BP. Elevated hyaluronan production induces mesenchymal and transformed properties in epithelial cells. J Biol Chem 2003;278:45801-10.
-
(2003)
J Biol Chem
, vol.278
, pp. 45801-45810
-
-
Zoltan-Jones, A.1
Huang, L.2
Ghatak, S.3
Toole, B.P.4
-
36
-
-
3042656633
-
Intracellular hyaluronan: A new frontier for inflammation?
-
Hascall VC, Majors AK, de la Motte CA, Evanko SP, Wang A, Drazba JA, et al. Intracellular hyaluronan: a new frontier for inflammation? Biochim Biophys Acta 2004;1673:3-12.
-
(2004)
Biochim Biophys Acta
, vol.1673
, pp. 3-12
-
-
Hascall, V.C.1
Majors, A.K.2
de la Motte, C.A.3
Evanko, S.P.4
Wang, A.5
Drazba, J.A.6
-
37
-
-
2342648113
-
Osteogenic protein-1 inhibits matrix depletion in a hyaluronan hexasaccharide-induced model of osteoarthritis
-
Nishida Y, Knudson CB, Knudson K. Osteogenic protein-1 inhibits matrix depletion in a hyaluronan hexasaccharide-induced model of osteoarthritis. Osteoarthritis Cartilage 2004;12:374-82.
-
(2004)
Osteoarthritis Cartilage
, vol.12
, pp. 374-382
-
-
Nishida, Y.1
Knudson, C.B.2
Knudson, K.3
-
38
-
-
3042697038
-
Hyaluronan: From extracellular glue to pericellular cue
-
Toole BP. Hyaluronan: from extracellular glue to pericellular cue. Nat Rev Cancer 2004;4:528-39.
-
(2004)
Nat Rev Cancer
, vol.4
, pp. 528-539
-
-
Toole, B.P.1
-
39
-
-
30344461304
-
Overexpression of hyaluronan synthases alters vascular smooth muscle cell phenotype and promotes monocyte adhesion
-
Wilkinson TS, Bressler SL, Evanko SP, Braun KR, Wight TN. Overexpression of hyaluronan synthases alters vascular smooth muscle cell phenotype and promotes monocyte adhesion. J Cell Physiol 2006;206:378-85.
-
(2006)
J Cell Physiol
, vol.206
, pp. 378-385
-
-
Wilkinson, T.S.1
Bressler, S.L.2
Evanko, S.P.3
Braun, K.R.4
Wight, T.N.5
-
40
-
-
18244402390
-
Immunologic roles of hyaluronan
-
Mummert ME. Immunologic roles of hyaluronan. Immunol Res 2005;31:189-206.
-
(2005)
Immunol Res
, vol.31
, pp. 189-206
-
-
Mummert, M.E.1
-
41
-
-
0033753655
-
Induction of hyaluronan metabolism after mechanical injury of human peritoneal mesothelial cells in vitro
-
Yung S, Thomas GJ, Davies M. Induction of hyaluronan metabolism after mechanical injury of human peritoneal mesothelial cells in vitro. Kidney Int 2000;58:1953-62.
-
(2000)
Kidney Int
, vol.58
, pp. 1953-1962
-
-
Yung, S.1
Thomas, G.J.2
Davies, M.3
-
42
-
-
1842790803
-
Differential regulation by IL-1β and EGF of expression of three different hyaluronan synthases in oral mucosal epithelial cells and fibroblasts and dermal fibroblasts: Quantitative analysis using real-time RT-PCR
-
Yamada Y, Itano N, Hata KI, Ueda M, Kimata K. Differential regulation by IL-1β and EGF of expression of three different hyaluronan synthases in oral mucosal epithelial cells and fibroblasts and dermal fibroblasts: quantitative analysis using real-time RT-PCR. J Invest Dermatol 2004;122:631-9.
-
(2004)
J Invest Dermatol
, vol.122
, pp. 631-639
-
-
Yamada, Y.1
Itano, N.2
Hata, K.I.3
Ueda, M.4
Kimata, K.5
-
43
-
-
0021888603
-
Influences of sulfated glycos-aminoglycans on biosynthesis of hyaluronic acid in rabbit knee synovial membrane
-
Nishikawa H, Mori I, Umemoto J. Influences of sulfated glycos-aminoglycans on biosynthesis of hyaluronic acid in rabbit knee synovial membrane. Arch Biochem Biophys 1985;240:146-53.
-
(1985)
Arch Biochem Biophys
, vol.240
, pp. 146-153
-
-
Nishikawa, H.1
Mori, I.2
Umemoto, J.3
-
44
-
-
0023749882
-
Glycosaminoglycan polysulfate-induced stimulation of hyaluronic acid synthesis in rabbit knee synovial membrane: Involvement of binding protein and calcium ion
-
Nishikawa H, Mori I, Umemoto J. Glycosaminoglycan polysulfate-induced stimulation of hyaluronic acid synthesis in rabbit knee synovial membrane: involvement of binding protein and calcium ion. Arch Biochem Biophys 1988;266:201-9.
-
(1988)
Arch Biochem Biophys
, vol.266
, pp. 201-209
-
-
Nishikawa, H.1
Mori, I.2
Umemoto, J.3
-
45
-
-
0025282411
-
CD44 is the principal cell surface receptor for hyaluronate
-
Aruffo A, Stamenkovic I, Melnick M, Underhill CB, Seed B. CD44 is the principal cell surface receptor for hyaluronate. Cell 1990;61:1303-13.
-
(1990)
Cell
, vol.61
, pp. 1303-1313
-
-
Aruffo, A.1
Stamenkovic, I.2
Melnick, M.3
Underhill, C.B.4
Seed, B.5
-
46
-
-
2642625456
-
Mechanism, localization, and inhibition of hyaluronate synthesis
-
Kuettner K, editor, New York: Raven Press;
-
Prehm P. Mechanism, localization, and inhibition of hyaluronate synthesis. In: Kuettner K, editor. Articular cartilage biochemistry. New York: Raven Press; 1986. p. 597-600.
-
(1986)
Articular cartilage biochemistry
, pp. 597-600
-
-
Prehm, P.1
-
47
-
-
0031733163
-
Hyaluronan production in human rheumatoid fibroblastic synovial lining cells is increased by interleukin 1β but inhibited by transforming growth factor β1
-
Kawakami M, Suzuki K, Matsuki Y, Ishizuka T, Hidaka T, Konishi T, et al. Hyaluronan production in human rheumatoid fibroblastic synovial lining cells is increased by interleukin 1β but inhibited by transforming growth factor β1. Ann Rheum Dis 1998;57:602-5.
-
(1998)
Ann Rheum Dis
, vol.57
, pp. 602-605
-
-
Kawakami, M.1
Suzuki, K.2
Matsuki, Y.3
Ishizuka, T.4
Hidaka, T.5
Konishi, T.6
-
48
-
-
1542305591
-
Differential effect of transforming growth factor β (TGF-β) on the genes encoding hyaluronan synthases and utilization of the p38 MAPK pathway in TGF-β-induced hyaluronan synthase 1 activation
-
Stuhlmeier KM, Pollaschek C. Differential effect of transforming growth factor β (TGF-β) on the genes encoding hyaluronan synthases and utilization of the p38 MAPK pathway in TGF-β-induced hyaluronan synthase 1 activation. J Biol Chem 2004;279:8753-60.
-
(2004)
J Biol Chem
, vol.279
, pp. 8753-8760
-
-
Stuhlmeier, K.M.1
Pollaschek, C.2
-
49
-
-
0031939945
-
Characterization and molecular evolution of a vertebrate hyaluronan synthase gene family
-
Spicer AP, McDonald JA. Characterization and molecular evolution of a vertebrate hyaluronan synthase gene family. J Biol Chem 1998;273:1923-32.
-
(1998)
J Biol Chem
, vol.273
, pp. 1923-1932
-
-
Spicer, A.P.1
McDonald, J.A.2
-
50
-
-
0019819928
-
Uridine diphosphate glucose dehydrogenase in rheumatoid synovial cells in culture
-
Ross GT, Marsh JM, Roback DW. Uridine diphosphate glucose dehydrogenase in rheumatoid synovial cells in culture. J Rheumatol 1981;8:710-5.
-
(1981)
J Rheumatol
, vol.8
, pp. 710-715
-
-
Ross, G.T.1
Marsh, J.M.2
Roback, D.W.3
-
51
-
-
0026713075
-
Uridine diphosphoglucose dehydrogenase activity in synovial lining cells in the experimental antigen induced model of rheumatoid arthritis: An indication of synovial lining cell function
-
Pitsillides AA, Blake SM. Uridine diphosphoglucose dehydrogenase activity in synovial lining cells in the experimental antigen induced model of rheumatoid arthritis: an indication of synovial lining cell function. Ann Rheum Dis 1992;51:992-5.
-
(1992)
Ann Rheum Dis
, vol.51
, pp. 992-995
-
-
Pitsillides, A.A.1
Blake, S.M.2
-
52
-
-
0027510607
-
Uridine diphosphoglucose dehydrogenase activity in normal and rheumatoid synovium: The description of a specialized synovial lining cell
-
Pitsillides AA, Wilkinson LS, Mehdizadeh S, Bayliss MT, Edwards JC. Uridine diphosphoglucose dehydrogenase activity in normal and rheumatoid synovium: the description of a specialized synovial lining cell. Int J Exp Path 1993;74:27-34.
-
(1993)
Int J Exp Path
, vol.74
, pp. 27-34
-
-
Pitsillides, A.A.1
Wilkinson, L.S.2
Mehdizadeh, S.3
Bayliss, M.T.4
Edwards, J.C.5
-
53
-
-
30044432227
-
Adenovirus-mediated gene transfer of mutated IκB kinase and IκBα reveal NF-κB-dependent as well as NF-κB-independent pathways of HAS1 activation
-
Stuhlmeier KM, Pollaschek C. Adenovirus-mediated gene transfer of mutated IκB kinase and IκBα reveal NF-κB-dependent as well as NF-κB-independent pathways of HAS1 activation. J Biol Chem 2005;280:42766-73.
-
(2005)
J Biol Chem
, vol.280
, pp. 42766-42773
-
-
Stuhlmeier, K.M.1
Pollaschek, C.2
-
54
-
-
33744831460
-
Recombinant human hyaluronan synthase 3 is phosphorylated in mammalian cells
-
Goentzel BJ, Weigel PH, Steinberg RA. Recombinant human hyaluronan synthase 3 is phosphorylated in mammalian cells. Biochem J 2006;396:347-54.
-
(2006)
Biochem J
, vol.396
, pp. 347-354
-
-
Goentzel, B.J.1
Weigel, P.H.2
Steinberg, R.A.3
-
55
-
-
0029160101
-
Biochemical and pharmacokinetic aspects of oral treatment with chondroitin sulfate
-
Conte A, Volpi N, Palmieri L, Bahous I, Ronca G. Biochemical and pharmacokinetic aspects of oral treatment with chondroitin sulfate. Arzneimittelforschung 1995;45:918-25.
-
(1995)
Arzneimittelforschung
, vol.45
, pp. 918-925
-
-
Conte, A.1
Volpi, N.2
Palmieri, L.3
Bahous, I.4
Ronca, G.5
-
56
-
-
0027725646
-
Metabolic fate of partially depolymerized shark chondroitin sulfate in man
-
Ronca G, Conte A. Metabolic fate of partially depolymerized shark chondroitin sulfate in man. Int J Clin Pharm Res 1993;13:27-34.
-
(1993)
Int J Clin Pharm Res
, vol.13
, pp. 27-34
-
-
Ronca, G.1
Conte, A.2
-
57
-
-
0027155862
-
Bioavailability of oral chondroitin sulfate
-
Lualdi P. Bioavailability of oral chondroitin sulfate. Rheumatol Int 1993;13:39-43.
-
(1993)
Rheumatol Int
, vol.13
, pp. 39-43
-
-
Lualdi, P.1
|